The Healthcare Sales & Marketing Network(R): Sales & Marketing News, Information and Networking for Medical Devices, Pharmaceuticals and Biotechnology.
Sales & Marketing News, Information and Networking for Medical Devices, Pharmaceuticals and Biotechnology.
Main Page: Medical News Roundups and more Medical Device and Biotech/Pharmaceutical News Medical Meetings and Conventions Calendar Message Boards for Medical Sales and Marketing Professionals, Distributors and Independent Sales Reps in Devices, Biopharmaceuticals and Diagnostics Medical Device and Biotech/Pharmaceutical Companies Members sections: News Roundups, News Archives, SuperSearch, Directory of Medical Sales and Marketing Professionals
Healthcare Sales & Marketing Network celebrates twelve years serving the medical device, biopharmaceutical and diagnostics community!
 
Company Profiles: Medical Devices, Biotechnology and Pharmaceuticals
       
Abbott Laboratories: PharmaVitae Profile

       
Acambis PLC: Premium Company Profile

       
Achillion Pharmaceuticals: Company Profile

       
Acorda Therapeutics: Premium Company Profile

       
Actelion Ltd: PharmaVitae Profile

       
Akzo Nobel/Organon: PharmaVitae Profile

       
Alcon Inc.: PharmaVitae Profile

       
Alexion Pharmaceuticals: Company Profile

       
Alexza Pharmaceuticals: Company Profile

       
Allergan: PharmaVitae Profile

       
Allos Therapeutics: Premium Company Profile

       
Almirall: PharmaVitae Profile

       
Alpharma: Premium Company Profile

       
Altana: PharmaVitae Profile

       
Altus Pharmaceuticals: Company Profile

       
Amgen Inc.: PharmaVitae Profile

       
Amylin Pharmaceuticals: Premium Company Profile

       
Anesiva Inc: Premium Company Profile

       
Antares Pharma: Premium Company Profile

       
Antisoma plc: Premium Company Profile

       
ArQule Inc: Premium Company Profile

       
Aspreva Pharmaceuticals Corporation: Premium Company Profile

       
Astellas: PharmaVitae Profile

       
AstraZeneca plc: PharmaVitae Profile

       
Auxilium Pharmaceuticals: Premium Company Profile

       
Avigen Inc: Premium Company Profile

       
Barr Pharmaceuticals Inc.: PharmaVitae Profile

       
Barrier Therapeutics: Premium Company Profile

       
Bayer Schering Pharma AG: PharmaVitae Profile

       
Beckman Coulter Inc: Premium Company Profile

       
Becton, Dickinson and Co: Premium Company Profile

       
Biogen Idec: PharmaVitae Profiles

       
BioMarin Pharmaceutical: Premium Company Profile

       
BIOMS Medical Corp: Premium Company Profile

       
Boehringer Ingelheim GmbH: PharmaVitae Profile

       
Boston Scientific Corporation: Premium Company Profile

       
Bracco: Company Profile

       
Bristol-Myers Squibb Co.: PharmaVitae Profile

       
C.R. Bard Inc: Premium Company Profile

       
Cardinal Health: Company Profile

       
Cardiome Pharma Corp: Premium Company Profile

       
Carl Zeiss Meditec AG: Premium Company Profile

       
Celgene Corporation: PharmaVitae Profile

       
Cephalon: PharmaVitae Profile

       
Chiron: PharmaVitae Profile

       
Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile

       
CollaGenex: Premium Company Profile

       
Cougar Biotechnology Inc: Premium Company Profile

       
CSL Limited: Premium Company Profile

       
Cubist Pharmaceuticals: Premium Company Profile

       
CuraGen: Premium Company Profile

       
CV Therapeutics: Premium Company Profile

       
Cypress Bioscience Inc: Premium Company Profile

       
Cytogen: Premium Company Profile

       
Cytokinetics Inc: Premium Company Profile

       
Cytori Therapeutics Inc: Premium Company Profile

       
Daiichi Sankyo: PharmaVitae Profile

       
Dainippon Sumitomo Pharma: PharmaVitae Profile 2005

       
Danaher Corporation: Premium Company Profile

       
Depomed: Premium Company Profile

       
Discovery Laboratories: Premium Company Profile

       
DURECT Corporation: Premium Company Profile

       
Dyax: Premium Company Profile

       
Dynavax Technologies Corp: Premium Company Profile

       
Eisai: PharmaVitae Profile

       
Elan Corporation: Premium Company Profile

       
Eli Lilly & Co.: PharmaVitae Profile

       
Encysive Pharmaceuticals: Premium Company Profile

       
Endo Pharmaceuticals: Premium Company Profile

       
EPIX Pharmaceuticals Inc: Premium Company Profile

       
F. Hoffmann-La Roche Ltd.: PharmaVitae Profile

       
Forest Laboratories: PharmaVitae Profile

       
Gedeon Richter: Premium Company Profile

       
Genentech Inc.: PharmaVitae Profile

       
Genmab: Premium Company Profile

       
Genzyme Corporation: PharmaVitae Profile

       
Gilead Sciences: PharmaVitae Profile

       
GlaxoSmithKline plc: PharmaVitae Profile

       
GPC Biotech AG: Premium Company Profile

       
GTC Biotherapeutics Inc: Premium Company Profile

       
GTx, Inc.: Premium Company Profile

       
Guerbet: Company Profile

       
H. Lundbeck: PharmaVitae Profile

       
Human Genome Sciences: Premium Company Profile

       
Idenix Pharmaceuticals: Premium Company Profile

       
Illumina Inc: Premium Company Profile

       
ImClone Systems: Premium Company Profile

       
ImmunoGen: Premium Company Profile

       
Incyte Corporation: Premium Company Profile

       
Introgen Therapeutics Inc: Premium Company Profile

       
Invitrogen Corporation: Premium Company Profile

       
Ipsen: PharmaVitae Profile

       
Javelin Pharmaceuticals Inc: Premium Company Profile

       
Johnson & Johnson: PharmaVitae Profile

       
Keryx Biopharmaceuticals: Premium Company Profile

       
King Pharmaceuticals: PharmaVitae Profile

       
KV Pharmaceutical Company: Premium Company Profile

       
La Jolla Pharmaceutical Co: Premium Company Profile

       
Lev Pharmaceuticals Inc: Premium Company Profile

       
Lexicon Pharmaceuticals Inc: Premium Company Profile

       
LifeCell Corporation: Premium Company Profile

       
Lundbeck: PharmaVitae Profile

       
MannKind Corporation: Premium Company Profile

       
Martek Biosciences Corp: Premium Company Profile

       
Maxygen: Premium Company Profile

       
Medarex: Premium Company Profile

       
MedImmune: PharmaVitae Profile

       
Medtronic Inc: Premium Company Profile

       
Menarini: PharmaVitae Profile

       
Merck & Co: PharmaVitae Profile

       
Merck Serono Biopharmaceuticals: PharmaVitae Profile

       
MGI Pharm: Premium Company Profile

       
Micromet Inc: Premium Company Profile

       
Millennium: PharmaVitae Profile

       
Mitsubishi: PharmaVitae Profile 2005

       
MorphoSys AG: Premium Company Profile

       
Mylan: PharmaVitae Profile

       
Nastech Pharmaceutical: Premium Company Profile

       
Neurocrine Biosciences: Premium Company Profile

       
Neurogen Corporation: Premium Company Profile

       
Novacea Inc: Premium Company Profile

       
Novartis AG: PharmaVitae Profile

       
Novavax: Premium Company Profile

       
Novo Nordisk A/S: PharmaVitae Profile

       
Nuvelo Inc: Premium Company Profile

       
Nycomed A/S: PharmaVitae Profile

       
Optimer Pharmaceuticals Inc: Premium Company Profile

       
Organon: PharmaVitae Profile

       
OSI Pharmaceuticals: Premium Company Profile

       
Pain Therapeutics: Premium Company Profile

       
Panacos Pharmaceuticals Inc: Premium Company Profile

       
Pfizer Inc.: PharmaVitae Profile

       
PharmaVitae Generics - Teva

       
PharmaVitae: Company Comparator Tool

       
Pharmion Corporation: Premium Company Profile

       
Philips Medical Systems: Company Profile

       
Pierre Fabre: PharmaVitae Profile

       
Poniard Pharmaceuticals Inc: Premium Company Profile

       
Progenics Pharmaceuticals: Premium Company Profile

       
QLT Inc: Premium Company Profile

       
Recordati: PharmaVitae Profile

       
Roche: PharmaVitae Profile

       
Sandoz: PharmaVitae Profile

       
sanofi-aventis: PharmaVitae Profile

       
Santarus: Premium Company Profile

       
Savient Pharmaceuticals: Premium Company Profile

       
Schering AG: PharmaVitae Profile

       
Schering-Plough Corporation: PharmaVitae Profile

       
Sepracor: PharmaVitae Profile

       
Serono: PharmaVitae Profile

       
Servier: PharmaVitae Profile

       
Shionogi: PharmaVitae Profile

       
Shire plc: PharmaVitae Profile

       
Smith & Nephew plc: Premium Company Profile

       
Solvay: PharmaVitae Profile

       
Sonus Pharmaceuticals Inc: Premium Company Profile

       
Spectrum Pharmaceuticals Inc: Premium Company Profile

       
St. Jude Medical Inc: Premium Company Profile

       
Stryker Corporation: Premium Company Profile

       
Sunesis Pharmaceuticals: Premium Company Profile

       
Takeda: PharmaVitae Profile

       
Tanox: Premium Company Profile

       
Teva Pharmaceutical Industries Ltd: PharmaVitae Profile

       
The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles

       
Theratechnologies Inc: Premium Company Profile

       
TorreyPines Therapeutics Inc: Premium Company Profile

       
Toshiba: Company Profile

       
Transition Therapeutics Inc: Premium Company Profile

       
UCB S.A.: PharmaVitae Profile

       
UCB Schwarz: PharmaVitae Profile

       
United Therapeutics: Premium Company Profile

       
Varian Medical Systems Inc: Premium Company Profile

       
Vertex Pharmaceuticals: Premium Company Profile

       
ViroPharma: Premium Company Profile

       
Warner Chilcott Ltd: Premium Company Profile

       
Watson Pharmaceuticals Inc.: PharmaVitae Profile

       
Wyeth: PharmaVitae Profile

       
Zimmer Holdings Inc: Premium Company Profile

       

 

 
     
Top Selling Reports...

Generic Series: Benchmarking Patent Expiries - Key Factors Affecting Brand Erosion at Patent Expiry

sanofi-aventis: PharmaVitae Profile

Commercial Insight: Asthma/COPD - ICS/LABA combinations continue to dominate

GTx, Inc.: Premium Company Profile

Pipeline Insight: Epilepsy - Pipeline drugs struggle to outshine their marketed predecessors

Dainippon Sumitomo Pharma: PharmaVitae Profile 2005

Stakeholder Insight: Pricing and Reimbursement in Oncology - Do payers believe oncology drugs offer good value?

Forecast Insight: Multiple Sclerosis - Tysabri to prevail despite safety setbacks

Generics: Global Industry Guide

Pharmaceutical Outsourcing Part 1: Contract Manufacturing Strategies - Offshoring is not the only option to drive productivity and efficiencies

Altus Pharmaceuticals: Company Profile

Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family

Pipeline Insight: Osteoarthritis - The Wait for a DMOAD Continues

Novacea Inc: Premium Company Profile

The Cardiovascular Market Outlook to 2011

Stakeholder Opinions: Osteoarthritis - Preconceptions Damage Awareness and Treatments

Pharmaceutical Growth Opportunities in the EU Accession States: Healthcare reform, market dynamics and key players

EPIX Pharmaceuticals Inc: Premium Company Profile

Schering AG: PharmaVitae Profile

H. Lundbeck: PharmaVitae Profile

Regulator Perceptions in Cancer - Evolving opinions about the oncology drug approval process

Biotechnology: Global Industry Guide

Pipeline Insight: Orphan Diseases in CNS - Part II: Amyotrophic Lateral Sclerosis

Commercial and Pipeline Insight: Vaccines for Adults and the Elderly - New blockbuster opportunities ahead

Achillion Pharmaceuticals: Company Profile

Immunomodulators: Therapeutic Needs, Pipelines & Prospects

The Pharmaceutical Industry: Key trends and strategic issues shaping the industry.

Stakeholder Insight: Non-Small Cell Lung Cancer - The need for greater product differentiation in an increasingly crowded market

Stakeholder Opinions: Biologics in Infectious Diseases Well defined target populations are key to commercial success

Mixed Urinary Incontinence - An Opportunity for Novel Drug Therapies

ViroPharma: Premium Company Profile

Pipeline Insight: Cancer Overview - Increasing diversity offers both high risk and reward

Tanox: Premium Company Profile

The Global Anti-Infectives Market Outlook to 2011

Forest Laboratories: PharmaVitae Profile

Patient Empowerment: empowered patients can change healthcare outcomes and impact the pharmaceutical industry

Cephalon: PharmaVitae Profile

Innovations in The Management of Diabetes: Next generation treatments and market dynamics

Stakeholder Opinion: Erectile Dysfunction - Identifying product differentiation and patient segmentation strategies

Stakeholder Opinions: Ovarian Cancer Growing importance as secondary indication for targeted therapies

Toshiba: Company Profile

Dyax: Premium Company Profile

Philips Medical Systems: Company Profile

Generics Series: Key trends and events in the 7 major markets

Pharmaceutical Branding Strategies: Thought leader perspectives on brand building, effective communication and future brand models

Stakeholder Insight: Parkinson's Disease - Evidence of neuroprotection essential to progress treatment dynamics

Cardinal Health: Company Profile

Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor types

eSampling Strategies: Using Internet Technologies to Increase Impact at the Point of Care

Carl Zeiss Meditec AG: Premium Company Profile

Guerbet: Company Profile

Stakeholder Opinions: Small Cell Lung Cancer and Malignant Mesothelioma - Limited R&D activity provides opportunity for early-phase pipeline drugs

Commercial Insight: Antihormonal Therapy Cancer Brands - Careful lifecycle management needed to preserve brand dominance

Improving Efficiencies through the Development of Claims Processing in Healthcare (Strategic Focus)

Commercial Insight: HIV - The battle for market share is getting fiercer

Generics: Global Industry Guide

The CNS Market Outlook to 2012

Using a Multi-faceted Approach to Increasing EHR Adoption (Strategy Focus)

The Asthma, COPD & Allergic Rhinitis Market Outlook to 2011

Cytori Therapeutics Inc: Premium Company Profile

Pipeline Insight: Depression - Novel drugs to grow third-line market

Business Blogging for Pharma

Eisai: PharmaVitae Profile

Stakeholder Insight: Acute Stroke - TPA spurs infrastructure changes for the better

Watson Pharmaceuticals Inc.: PharmaVitae Profile

Sales Force Effectiveness

Drug Repositioning Strategies - Serendipity by design

Acorda Therapeutics: Premium Company Profile

GTC Biotherapeutics Inc: Premium Company Profile

Pipeline Insight: Non-Small Cell Lung Cancer - Pipeline set to offer only modest improvements

Santarus: Premium Company Profile

Future Growth Opportunities in Generics: The impact of consolidation on market and competitive dynamics

Stryker Corporation: Premium Company Profile

Pipeline Insight: Cancer Overview - Lung, Brain, Head and Neck, Thyroid

Stakeholder Opinions: Diagnostics in Neurology - Predictive biomarkers expand drug revenues

Pricing & Reimbursement Series: Medicare Part D's progress so far

Management of Urinary Incontinence and Overactive Bladder - A Global Overview

Financial Markets Research: ASCO Review Part I - A summary of highlights presented at the ASCO 2006 Annual Meeting

Forecast Insight: Migraine - Generic incursion inhibits market growth

Pipeline Insight: Heart failure Weak pipeline dominated by new indications and add-on diuretics

Pipeline/Commercial Insight: Supportive Care in Oncology - Significant growth opportunities exist in new supportive care indications

Discovery Laboratories: Premium Company Profile

Elan Corporation: Premium Company Profile

Financial Markets Research: ASCO Review Part II - A summary of highlights presented at the ASCO 2006 Annual Meeting

Generic Series: Optimizing Brand Lifecycle Management Winning Strategies to Maximize Revenue in the Face of Growing Generic Competition

Biosimilars: Benchmarking the key players - With increasing regulatory clarity and high revenue potential, interest in biosimilars increases

MedImmune: PharmaVitae Profile

The Future of Biosimilars: Key opportunities & emerging therapies

Pipeline Insight: Non-insulin antidiabetics – Incretin mimetics – leaders in a diverse pipeline

Commercial Insight: Cardiovascular market overview - Raft of patent expires threaten blockbusters

Pricing & Reimbursement in Europe: Can the drive for cost effectiveness overcome cost containment?

Taking CRM to the Next Level: Web-assisted relationship- and community-building for the pharmaceutical industry

Commercial Insight: Top 20 Therapy Cancer Brands - Key brands set to consolidate advantage as competition intensifies

Stakeholder Opinions: Endometriosis - Scientific clarity will unlock market potential

Biosimilars Series: Stakeholder Analysis

Alexza Pharmaceuticals: Company Profile

Global Generics Guide: Benchmarking the key players

Commercial Insight: Multiple Sclerosis Continued growth makes the MS market a highly attractive investment

Novavax: Premium Company Profile

Monoclonal Antibodies Report: 2008 Update



 

 

 HOME    •    NEWSFEED    •     MEETINGS & CONVENTIONS    •    FORUM    •    LINKS    •    TOP   
Copyright © 1998-2010 The Healthcare Sales & Marketing Network. All rights reserved.
The Healthcare Sales & Marketing Network is a registered trademark of Healthcare Sales & Marketing Network, LLC.
Powered by Redhat Enterprise Linux 4ES